UCB and Biogen's Phase 3 lupus drug trial shows improved disease activity outcomes, with promising data leading to a second ...

Drinking beetroot juice before a workout could enhance the benefits of exercise training in postmenopausal women, according ...

Mizuho lowered the firm’s price target on Biogen (BIIB) to $207 from $251 and keeps an Outperform rating on the shares. The analyst updated ...

Place your right elbow directly underneath your right shoulder. Engage your core and slowly lift your hips off of the mat, ...

A phase 3 trial of Biogen (NASDAQ:BIIB) and UCB's (OTCPK:UCBJF)(OTCPK:UCBJY) dapirolizumab pegol for systemic lupus erythematosus met its primary endpoint, demonstrating significant improvement in ...

Leoni Jesner is a fitness and health writer contributing content to Verywell Fit, Byrdie, Forbes Health, Everyday Health and Insider, as well as providing expert features to LIVESTRONG, Bustle ...

UCB and Biogen Inc. (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, a Fc-free ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing ...

What are the best nutrients to be taking to boost your training? Whether you’re looking for performance enhancement or muscle ...

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs.